96 related articles for article (PubMed ID: 8536714)
1. Complexes of tissue kallikrein with protein C inhibitor in human semen and urine.
España F; Fink E; Sanchez-Cuenca J; Gilabert J; Estellés A; Witzgall K
Eur J Biochem; 1995 Dec; 234(2):641-9. PubMed ID: 8536714
[TBL] [Abstract][Full Text] [Related]
2. A quantitative ELISA for the measurement of complexes of prostate-specific antigen with protein C inhibitor when using a purified standard.
España F; Sanchez-Cuenca J; Vera CD; Estelles A; Gilabert J
J Lab Clin Med; 1993 Dec; 122(6):711-9. PubMed ID: 7504042
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma.
España F; Estellés A; Fernández PJ; Gilabert J; Sánchez-Cuenca J; Griffin JH
Thromb Haemost; 1993 Dec; 70(6):989-94. PubMed ID: 8165623
[TBL] [Abstract][Full Text] [Related]
4. Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen.
Christensson A; Lilja H
Eur J Biochem; 1994 Feb; 220(1):45-53. PubMed ID: 7509746
[TBL] [Abstract][Full Text] [Related]
5. Heparin binding of protein-C inhibitor--analysis of the effect of heparin on the interaction of protein-C inhibitor with tissue kallikrein.
Ecke S; Geiger M; Binder BR
Eur J Biochem; 1997 Sep; 248(2):475-80. PubMed ID: 9346305
[TBL] [Abstract][Full Text] [Related]
6. Functionally inactive protein C inhibitor in seminal plasma may be associated with infertility.
He S; Lin YL; Liu YX
Mol Hum Reprod; 1999 Jun; 5(6):513-9. PubMed ID: 10340997
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tissue kallikrein by protein C inhibitor. Evidence for identity of protein C inhibitor with the kallikrein binding protein.
Ecke S; Geiger M; Resch I; Jerabek I; Sting L; Maier M; Binder BR
J Biol Chem; 1992 Apr; 267(10):7048-52. PubMed ID: 1313031
[TBL] [Abstract][Full Text] [Related]
8. Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen.
España F; Gilabert J; Estellés A; Romeu A; Aznar J; Cabo A
Thromb Res; 1991 Nov; 64(3):309-20. PubMed ID: 1725227
[TBL] [Abstract][Full Text] [Related]
9. The role of protein C inhibitor in human reproduction.
España F; Navarro S; Medina P; Zorio E; Estellés A
Semin Thromb Hemost; 2007 Feb; 33(1):41-5. PubMed ID: 17253188
[TBL] [Abstract][Full Text] [Related]
10. Diversity of human plasma protein C inhibitor.
Saito A
Thromb Res; 2012 Oct; 130(4):661-6. PubMed ID: 22206708
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the trypsin-like human prostatic kallikrein, also known as hK2, in the seminal plasma of infertile men: respective contributions of an ELISA procedure and of Western blotting.
Tremblay RR; Coulombe E; Cloutier S; Brunet C; Deperthes D; Frenette G; Dubé JY
J Lab Clin Med; 1998 Apr; 131(4):330-5. PubMed ID: 9579386
[TBL] [Abstract][Full Text] [Related]
12. The interaction among protein C inhibitor, prostate-specific antigen, and the semenogelin system.
Suzuki K; Kise H; Nishioka J; Hayashi T
Semin Thromb Hemost; 2007 Feb; 33(1):46-52. PubMed ID: 17253189
[TBL] [Abstract][Full Text] [Related]
13. Possible identity of kallikrein binding protein with protein C inhibitor.
Ecke S; Geiger M; Resch I; Jerabek I; Maier M; Binder BR
Agents Actions Suppl; 1992; 38 ( Pt 1)():182-9. PubMed ID: 1334618
[TBL] [Abstract][Full Text] [Related]
14. alpha2-macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein.
Heeb MJ; España F
Blood Cells Mol Dis; 1998 Dec; 24(4):412-9. PubMed ID: 9851894
[TBL] [Abstract][Full Text] [Related]
15. Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma.
Deperthes D; Chapdelaine P; Tremblay RR; Brunet C; Berton J; Hébert J; Lazure C; Dubé JY
Biochim Biophys Acta; 1995 Dec; 1245(3):311-6. PubMed ID: 8541306
[TBL] [Abstract][Full Text] [Related]
16. Vitronectin modulates glycosaminoglycan dependent reactions of protein C inhibitor.
Seiffert D; Geiger M; Ecke S; Binder BR
Thromb Haemost; 1992 Dec; 68(6):657-61. PubMed ID: 1283793
[TBL] [Abstract][Full Text] [Related]
17. Purification of enzymatically active kallikrein hK2 from human seminal plasma.
Frenette G; Deperthes D; Tremblay RR; Lazure C; Dubé JY
Biochim Biophys Acta; 1997 Feb; 1334(1):109-15. PubMed ID: 9042371
[TBL] [Abstract][Full Text] [Related]
18. Complex formation between urokinase and plasma protein C inhibitor in vitro and in vivo.
Geiger M; Huber K; Wojta J; Stingl L; Espana F; Griffin JH; Binder BR
Blood; 1989 Aug; 74(2):722-8. PubMed ID: 2752144
[TBL] [Abstract][Full Text] [Related]
19. Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma.
España F; Estelles A; Griffin JH; Aznar J
Thromb Haemost; 1991 Jan; 65(1):46-51. PubMed ID: 1850876
[TBL] [Abstract][Full Text] [Related]
20. Urinary protein C inhibitor. Glycosaminoclycans synthesized by the epithelial kidney cell line TCL-598 enhance its interaction with urokinase.
Geiger M; Priglinger U; Griffin JH; Binder BR
J Biol Chem; 1991 Jun; 266(18):11851-7. PubMed ID: 1646816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
